P osterior circulation infarction accounts for 25%-30% of all ischemic infarcts.
durations. 2, 9, 10, 14, 25 Microsurgical revascularization can be performed by proximal VA endarterectomy, 5 VA-common carotid artery (CCA) transposition, 2, 10, 14 and graft interposition techniques. 9 Indeed, most reports of VA revascularization have described a combination of the aforementioned techniques for augmenting flow to the posterior circulation. We sought to evaluate the outcomes of patients with medically refractory vertebrobasilar insufficiency treated with VA-CCA transposition, emphasizing the longterm outcomes and rates of complications in this group.
Methods

Patient Population
A retrospective analysis from the prospective vascular database of the Barrow Neurological Institute was performed on patients who had VA-CCA transposition.
Between 2005 and 2013, we treated 22 patients with medically refractory vertebrobasilar insufficiency using VA-CCA transposition at the Barrow Neurological Institute (Table 1) . A medically refractory condition was indicated if the patients had persistent symptoms attributable to posterior circulation ischemia despite an adequate trial of best medical therapy. There were 17 men (77%) and 5 women (23%) with an average age of 69.1 years (range 48-81 years). Their medical records, neurological examinations, and radiographic studies were reviewed retrospectively. The patients' pre-and postoperative neurological function was evaluated using modified Rankin Scale scores.
Diagnostic evaluation
All the patients underwent digital subtraction angiography, CT angiography (CTA), or MR angiography (Figs. 1 and 2).
Surgical technique
We have previously described our VA-CCA transposition technique (Videos 1 and 2).
14 ViDeO 1. A 52-year-old man had a history of symptomatic VA stenosis. Imaging was significant for severe stenosis of the left VA at its origin. The patient was advised to undergo a left VA-CCA transposition. A 4-cm incision along the anterior border of the sternocleidomastoid muscle, beginning at the superior edge of the clavicle, is used for access. After exposing the left CCA just superior to the clavicle, the thoracic duct is dissected out, ligated, and divided. The VA is identified and traced as inferiorly as possible. The proximal VA is ligated and divided after heparinization, and the CCA is occluded and rotated to allow anastomosis to the posterior lateral wall. A running 6-0 Prolene suture is used to perform the anastomosis, which is then back-bled, and patency is confirmed with an intraoperative ICG angiogram. Copyright Barrow Neurological Institute. Published with permission. Click here to view with Media Player. Click here to view with Quicktime.
ViDeO 2.
A 64-year-old woman had symptomatic VA stenosis. Imaging was significant for severe stenosis of the left VA at its origin. The patient underwent a left VA-CCA transposition. A 4.5-cm incision along the anterior border of the sternocleidomastoid muscle, beginning at the superior edge of the clavicle, is used for access. After exposing the left CCA just superior to the clavicle, multiple thoracic ducts are dissected out, ligated, and divided. The VA is identified and traced as inferiorly as possible. Intraoperative ICG angiography demonstrated lack of blood flow to the VA. The proximal VA is cut without ligation to verify patency and blood flow.
The proximal portion of the VA is clamped. A Fogarty balloon is inserted into the distal VA, and a thrombectomy is performed until adequate backflow is obtained. Then the artery is irrigated and heparinized. The CCA is occluded and rotated to allow anastomosis to the posterior lateral wall. A running 6-0 Prolene suture is used to perform the anastomosis, which is then back-bled, and patency is confirmed with an intraoperative ICG angiogram. Copyright Barrow Neurological Institute. Published with permission. Click here to view with Media Player. Click here to view with Quicktime.
Surgery is performed under general anesthesia. Somato sensory evoked potential monitoring and electroencephalography are routinely used. Barbiturate-burst suppression is induced before vascular clamping and maintained during occlusion. The head is kept in a neutral position with no extension (to prevent stretching of the muscle). A 6-to 8-cm linear incision is made along the medial border of the sternocleidomastoid muscle. Both muscle heads are dissected and separated. (The clavicular head is no longer taken, as we used to do in the past.) Dissection is carried down until the CCA is identified and isolated. The jugular vein is identified and isolated. Special attention must be paid to the thoracic duct, especially on the left side. This pale vessellike structure should be identified on the fat pad deep to the jugular vein; it is ligated and divided. It is not uncommon to encounter more than 1 thoracic duct (Video 2).
The VA is identified using anatomical landmarks. The thyrocervical trunk originates from the subclavian artery and is visualized first. Medial to this trunk, the VA can be identified. The VA can be distinguished from the thyrocervical and costocervical trunks by the lack of branches on its proximal segment. The C-6 transverse process can be palpated to guide identification and localization of this vessel. The CCA and VA are isolated and liberated from adhesions.
The CCA is the site most commonly used to implant the transposed VA. The initial step is to ligate the VA at its origin with hemoclips. The VA is divided, and the lumen is inspected. The VA is clamped with a temporary aneurysm clip at the level of the transverse foramen. The lumen is irrigated with heparinized saline. The CCA is clamped proximal and distal to the planned level of the arteriotomy. Using the vascular clamps, the CCA is rotated slightly to bring the back wall of the vessel up, facilitating the anastomosis and enabling it to be seated further posteriorly in a better anatomical position at the conclusion of the procedure.
Using a No. 11 blade followed by a 4-mm-diameter arteriotomy punch, the arteriotomy is performed. The vessel is fishmouthed as needed to tailor it to the diameter of the CA arteriotomy. A 60 monofilament Prolene (Ethicon, Inc.) is used for the anastomosis. After one side is done, the lumen is inspected. The procedure is then performed on the second side.
Before the suture line is closed, the distal VA is temporarily unclamped and allowed to back-bleed. The lumen is irrigated with heparinized saline. All arterial clamps are released. Small bleeding points at the suture line are usually self-limited and can be controlled with the use of Surgifoam (Ethicon, Inc.). Videoangiography with indocyanine green (ICG) is performed intraoperatively to check patency. The sternocleidomastoid muscle is reapproximated, and the wound is closed.
All patients in this study were treated using this technique. The patients were all on aspirin therapy.
results
Patient characteristics
The clinical parameters of the patients included in this study can be found in Table 1 . Of the 22 patients in the study, 12 had a significant history of tobacco use, 2 had no documentation of smoking history, and the remaining 8 were nonsmokers. Sixteen patients were hypertensive and were actively being treated with antihypertensive medications. Six patients had no documented history of hypertension. Eleven patients were actively treated for hyperlipidemia, and 17 patients were on antiplatelet or anticoagulation therapy (12 patients on antiplatelet and anticoagulation therapy, 4 on antiplatelet therapy only, and 1 on anticoagulation therapy only). Two patients had a history of myocardial infarction, and 3 patients had undergone carotid endarterectomy for anterior circulation ischemia. Thirteen patients presented with a history of cerebrovascular accident (CVA) or transient ischemic attack (TIA), 1 patient presented with subarachnoid hemorrhage, and the remainder presented with symptoms suggestive of ver tebrobasilar insufficiency. Two patients had previously undergone stenting and angioplasty procedures of the affected side without improvement of symptoms. The left side was more commonly involved (15 on the left vs 7 on the right). In a majority of the patients (n = 18), the contralateral VA was noted to exhibit mild to severe stenosis.
Morbidity and Mortality
There were no cases of perioperative death in this series. We identified 3 cases of recurrent laryngeal nerve palsy, 1 of which had not resolved at latest follow-up, 4 cases of temporary Horner's syndrome, 2 cases of postoperative TIA, and 1 case of thoracic duct injury associated with a left-sided approach (Table 2) .
Follow-up
Clinical follow-up information was available for 20 patients. At a mean clinical follow-up of 4.4 months (range postoperatively to 17 months), all patients had resolution or improvement of their presenting symptoms (Figs. 1  and 2 ). At a mean angiographic follow-up of 8.8 months, clinically significant restenosis was evident in a single case. This patient was treated with stenting 3 months after the microsurgical revascularization. 
Discussion
Previous reports of microsurgical revascularization of the proximal VA consisted of small cohorts of patients treated with a diverse array of revascularization techniques.
2,5,9,10,14,25 These techniques included endarterectomy of the proximal VA and subclavian artery, 5 VA-CCA transposition, 14 and placement of interposition grafts. 9 These series consisted of relatively short-term follow-up and focused on immediate symptom improvement (Table   3) . Still, there are no randomized data on the benefit of revascularization of the proximal VA for stroke prevention. However, cervical carotid trials 11, 12, 23 and case series support microsurgical or endovascular treatment. The goal for either treatment is successful resolution of the patients' symptoms and an angiographic result (< 50% residual stenosis) without neurological or procedurerelated complications. 14 The success rates of both modalities are similar, ranging from 93% to 98%. Here we have presented a series of 22 consecutively treated patients with medically refractory posterior circulation ischemia who underwent VA-CCA transposition. A majority of the patients in this series had an extensive history of tobacco use and hypertension. Seventyfive percent of the patients were treated aggressively with antiplatelet therapy, anticoagulation therapy, or both therapies. In 50% of the cases, the patients presented with a completely occluded contralateral VA, and a majority of the patients presented after suffering a CVA or TIA, in accordance with previous literature. For all the patients treated microsurgically, we identified resolution or improvement of their symptoms and adequate angiographic results. To our knowledge, this population represents the largest cohort of patients treated with this strategy to date.
When selecting the method of choice for revascularization of the proximal VA, the durability of the treatment becomes crucial. Albuquerque et al. 1 found restenosis in 43.3% of patients who underwent angioplasty and stenting for revascularization of the proximal VA. Similar results have consistently been reported in other studies. 1, 19, 20, 26 In the Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries trial, 43% of the patients who received treatment for extracranial VA stenosis and had 6 months of follow-up had evidence of in-stent stenosis. Half of them had a complete vessel occlusion. 26 Recently, Li et al. 18 demonstrated the efficacy of balloon-assisted angioplasty and self-expanding stents in 32 patients with symptomatic VA ostium stenosis. The mean extent of stenosis before and after stenting declined from 76.4% to 11.4%, and only 1 patient (3.1%) developed asymptomatic restenosis at a mean angiographic followup of 12.5 months. Drug-eluting stents can reduce restenosis rates by inhibiting neointimal hyperplasia, but the stent fracture rate is significantly high. The durability of microsurgical revascularization has been described extensively. 9, 10, 14, 16, 17, 19 Hanel et al. 14 reported that 7% of patients developed new or recurrent vertebrobasilar symptoms after surgery (mean follow-up 29 months). Their angiographic results showed only 1 case of recurrent stenosis among those patients who underwent follow-up imaging. Berguer et al. 2 reported a 71% 5-year survival rate for patients with extracranial VA disease undergoing microsurgical revascularization. A majority of the patients who died did so as a result of cardiac disease. Of those patients with 5 years of follow-up after microsurgical intervention, 97% remained stroke free. 2 In the present series, in a mean follow-up period of 8.8 months, 1 patient had restenosis 3 months after the microvascular procedure and required endovascular stenting.
temporary and Permanent complications
Complications of endovascular treatment for VA stenosis are variable. Parkhutik et al. 24 reported a neurological complication rate of 3.4%, with 1 immediate vertebral TIA and 2 other strokes during a mean 32-month follow-up period. Fiorella et al. 13 reported periprocedural neurological morbidity and mortality rates of 26.1%, including 10 clinically evident strokes, in patients with vertebrobasilar atheromatous disease undergoing endovascular treatment. Mohammadian et al. 22 recently presented their experience in using angioplasty and stenting to treat symptomatic VA stenosis and found periprocedural and follow-up complication rates of 7.2% and 6.3%, respectively. Microsurgical revascularization of the VA has inherent risks of complication from soft-tissue manipulation, such as wound infection or hematoma, laryngeal nerve injury, thrombosis, lymphatic injury, Horner's syndrome, and stroke. In a large series that included 218 proximal VA transpositions, Berguer et al. 2 found a mortality rate of 0.6% and a perioperative stroke rate of 1.9%. Their patency rate at 5 years was 80%. Hanel et al.
14 reported incidence rates of 48.3% for transient and 7.4% for permanent neurological deficits. Only 2 patients had new symptoms related to vertebrobasilar insufficiency, and 1 patient had a new distal vertebral stenosis 17 years after surgery.
In the current series, we did not identify any cases of perioperative death associated with this treatment strategy, but we did identify an array of temporary complications and 1 permanent complication. We noted recurrent laryngeal nerve palsies in 3 patients. This complication was temporary in all of them except for 1 at last followup. There was 1 case of a thoracic duct injury associated with a leftsided approach that was identified intraoperatively and treated without sequelae. We identified 4 cases of temporary Horner's syndrome and 2 cases of perioperative TIA. Postoperative CVAs have been reported in association with both microsurgical and endovascular treatment of the proximal VA and seem to be associated with manipulation of the atherosclerotic burden within the vessel. Anatomical knowledge and gentle tissue manipulation are the bases for avoiding complications.
conclusions
Despite advancements in medical therapy, a subset of patients with vertebrobasilar insufficiency remain candidates for microsurgical revascularization of the posterior circulation. Although endovascular management has contributed to a decline in the surgical treatment of vertebrobasilar insufficiency, the longterm outcomes for patients subjected to this regimen remain limited, and the rates of restenosis, even with drug-eluting stents, remain high. In experienced hands, microsurgical revascularization of the proximal VA using VA-CCA transposition is a safe and effective treatment for medically refractory vertebrobasilar insufficiency. 
